cGAS-STING signalings potentiate tumor progression via sustaining cancer stemness

Fu-Rao Liu1, Ming-Jie Jiang2, Zhu Mei1

  • 1Shanghai Key Laboratory of Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.

Insights

The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway fuels cancer stemness, promoting tumor growth and metastasis. Inhibiting this pathway may offer new cancer treatment strategies by targeting cancer stem cells.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • The cGAS-STING pathway, a key cytosolic DNA sensor, is implicated in tumor progression and immunotherapy response.
  • Its specific role in maintaining cancer stemness remains largely unexplored.

Purpose of the Study:

  • To investigate the role of the cGAS-STING pathway in regulating cancer stemness and tumor progression.
  • To elucidate the underlying molecular mechanisms, particularly the involvement of STAT3.

Main Methods:

  • Utilized cGAS- or STING-knockout tumor cells in vitro (tumorsphere formation) and in vivo (tumor formation assays).
  • Performed RNA-sequencing (RNA-seq) analysis to identify molecular pathways regulated by cGAS-STING.
  • Assessed tumor apoptosis, growth, and metastasis in knockout versus wild-type models.

Main Results:

  • The cGAS-STING pathway was found to be activated in various tumor cells.
  • Loss of cGAS or STING significantly impaired tumor formation, reduced tumor growth and metastasis, and increased apoptosis.
  • The cGAS-STING pathway sustains cancer stemness, likely through the activation of STAT3, as indicated by RNA-seq data.

Conclusions:

  • Intrinsic activation of the cGAS-STING pathway plays a crucial role in tumorigenesis and progression.
  • The pathway sustains cancer stemness via STAT3 activation, representing a novel mechanism in tumor development.
  • Targeting the cGAS-STING-STAT3 axis could be a potential therapeutic strategy for cancer treatment.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K